GHK-Cu peptide claims on TikTok: what the science says

What's this video probably claiming?

Based on the caption and hashtag context, @charley.wow is promoting GHK-Cu (copper tripeptide-1) as a "cellular-level" support agent for collagen production, skin repair, and hair health. The framing of "this isn't just skincare" is a classic move to elevate a topical or injectable compound into something more medicalized than a moisturizer. The creator likely discusses GHK-Cu's copper-binding properties and its reputation in peptide communities as an anti-aging compound. The phrase "consistency is key" signals the creator is probably managing expectations while still positioning the peptide as meaningfully superior to standard skincare. What the video almost certainly does not do is distinguish between topical GHK-Cu formulations (widely available, low-regulated) and compounded injectable versions (a very different regulatory and clinical situation). That distinction matters enormously, and glossing over it is where a lot of these videos go sideways.

What does the science actually show?

GHK-Cu has a genuinely interesting research footprint, which is partly why it keeps trending. Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK-Cu work and found the peptide stimulates collagen and glycosaminoglycan synthesis in fibroblast cultures, activates antioxidant genes, and shows wound-healing activity in animal models. Leyden et al. published clinical data showing topical GHK-Cu improved skin laxity and fine lines in a 12-week RCT, though effect sizes were modest. On hair, a few small studies suggest GHK-Cu may stimulate hair follicle enlargement and extend the anagen growth phase. The numbers here are underwhelming: one study (Uno and Kurata, 1993) showed follicle size increases of roughly 40% in a minoxidil-comparison model on macaques. That sounds big until you realize it was a non-human study and has never been replicated in a powered human trial. The collagen-support data in living humans, outside of topical cosmetic studies, is thin. Injectable GHK-Cu in humans remains largely unstudied in formal clinical settings.

Where does the social media noise diverge from clinical reality?

The gap between TikTok claims and clinical evidence on GHK-Cu is wide in a specific direction: delivery mechanism. Nearly every study showing meaningful biological effects uses either in vitro cell cultures or animal models. Human RCTs are mostly limited to topical cosmetic-grade products, not compounded injectables. When creators say "cellular-level support," they are technically borrowing language from lab studies and applying it as if those results translate directly to what you put in a syringe or on your face. They do not, automatically. There is also a dosing problem. Effective concentrations in fibroblast studies range from 0.1 to 10 nanomolar, but the concentrations in most commercial topicals and compounded formulations vary widely and are rarely disclosed. The FDA has not approved GHK-Cu as a drug for any indication. Compounded injectable GHK-Cu exists in a gray regulatory space, and no creator on TikTok is going to walk you through that complexity in a 60-second clip. The "blue peptide everyone's talking about" framing is trend-laundering, not evidence review.

What should you actually know?

GHK-Cu is not a scam, but it is also not a proven systemic anti-aging therapy. The topical evidence for modest improvements in skin texture and firmness is real, though effect sizes in human studies are small and industry-funded trials dominate the literature. The hair health claims are based on weak, older animal data and have not been confirmed in rigorous human trials. If you are considering GHK-Cu through a telehealth or compounding pharmacy channel, the questions that actually matter are: what is the concentration, what is the delivery method, and what is the clinical rationale your prescriber is using? Injectable peptide therapy operates under a specific regulatory framework, and any platform offering it should be working within that framework, not just amplifying TikTok trends. No one should be choosing a compounded peptide because a creator called it "the blue peptide everyone's talking about." That is marketing language, not clinical guidance.